Combined Use of Anti-VEGF Drugs Before and During Pars Plana Vitrectomy for Severe Proliferative Diabetic Retinopathy.

Xincheng SunXianhuai WangXinyu GuoMengjiao WangHu Liu

Published in: Ophthalmology and therapy (2023)

The combined use of anti-VEGF drugs before and during PPV in patients with severe PDR not only includes the advantages of preoperative injection, but also has more significant prognostic benefits and favourable safety profiles.

Keyphrases

diabetic retinopathy
vascular endothelial growth factor
optical coherence tomography
endothelial cells
early onset
drug induced
patients undergoing